These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 19307800

  • 1. Requirement of protocol biopsy before and after complete cessation of immunosuppression after liver transplantation.
    Yoshitomi M, Koshiba T, Haga H, Li Y, Zhao X, Cheng D, Miyagawa A, Sakashita H, Tsuruyama T, Ohe H, Ueda M, Okamoto S, Egawa H, Wood K, Sakaguchi S, Manabe T, Tanaka K, Uemoto S.
    Transplantation; 2009 Feb 27; 87(4):606-14. PubMed ID: 19307800
    [Abstract] [Full Text] [Related]

  • 2. Clinical, immunological, and pathological aspects of operational tolerance after pediatric living-donor liver transplantation.
    Koshiba T, Li Y, Takemura M, Wu Y, Sakaguchi S, Minato N, Wood KJ, Haga H, Ueda M, Uemoto S.
    Transpl Immunol; 2007 Feb 27; 17(2):94-7. PubMed ID: 17306739
    [Abstract] [Full Text] [Related]

  • 3. The presence of Foxp3 expressing T cells within grafts of tolerant human liver transplant recipients.
    Li Y, Zhao X, Cheng D, Haga H, Tsuruyama T, Wood K, Sakaguchi S, Tanaka K, Uemoto S, Koshiba T.
    Transplantation; 2008 Dec 27; 86(12):1837-43. PubMed ID: 19104431
    [Abstract] [Full Text] [Related]

  • 4. Steroid-free immunosuppression after liver transplantation does not increase the risk of graft fibrosis.
    Manzia TM, Toti L, Angelico R, Di Cocco P, Orlando G, Tisone G.
    Transplant Proc; 2010 May 27; 42(4):1237-9. PubMed ID: 20534270
    [Abstract] [Full Text] [Related]

  • 5. Adult living-donor liver transplantation with ABO-incompatible grafts.
    Testa G, Vidanovic V, Chejfec G, Gangemi A, Iqpal R, Porubsky M, Pham T, Benedetti E.
    Transplantation; 2008 Mar 15; 85(5):681-6. PubMed ID: 18337660
    [Abstract] [Full Text] [Related]

  • 6. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
    Pons JA, Revilla-Nuin B, Baroja-Mazo A, Ramírez P, Martínez-Alarcón L, Sánchez-Bueno F, Robles R, Rios A, Aparicio P, Parrilla P.
    Transplantation; 2008 Nov 27; 86(10):1370-8. PubMed ID: 19034005
    [Abstract] [Full Text] [Related]

  • 7. Significance of central perivenulitis in pediatric liver transplantation.
    Abraham SC, Freese DK, Ishitani MB, Krasinskas AM, Wu TT.
    Am J Surg Pathol; 2008 Oct 27; 32(10):1479-88. PubMed ID: 18708942
    [Abstract] [Full Text] [Related]

  • 8. Graft fibrosis after pediatric liver transplantation: ten years of follow-up.
    Scheenstra R, Peeters PM, Verkade HJ, Gouw AS.
    Hepatology; 2009 Mar 27; 49(3):880-6. PubMed ID: 19101912
    [Abstract] [Full Text] [Related]

  • 9. Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match.
    Ohe H, Waki K, Yoshitomi M, Morimoto T, Nafady-Hego H, Satoda N, Li Y, Zhao X, Sakaguchi S, Uemoto S, Bishop GA, Koshiba T.
    Transpl Int; 2012 Jan 27; 25(1):97-106. PubMed ID: 22117557
    [Abstract] [Full Text] [Related]

  • 10. Natural history of unexplained chronic hepatitis after liver transplantation.
    Syn WK, Nightingale P, Gunson B, Hubscher SG, Neuberger JM.
    Liver Transpl; 2007 Jul 27; 13(7):984-9. PubMed ID: 17520743
    [Abstract] [Full Text] [Related]

  • 11. Quality of life and problems affecting recipients more than 10 years after living donor liver transplantation.
    Kawagishi N, Takeda I, Miyagi S, Satoh K, Akamatsu Y, Sekiguchi S, Satomi S.
    Transplant Proc; 2009 Jul 27; 41(1):236-7. PubMed ID: 19249523
    [Abstract] [Full Text] [Related]

  • 12. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
    Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.
    Transplant Proc; 2009 Apr 27; 41(3):1041-3. PubMed ID: 19376421
    [Abstract] [Full Text] [Related]

  • 13. Graft fibrosis in patients with biliary atresia after pediatric living-related liver transplantation.
    Ueno T, Tanaka N, Ihara Y, Takama Y, Yamada H, Mushiake S, Fukuzawa M.
    Pediatr Transplant; 2011 Aug 27; 15(5):470-5. PubMed ID: 21771230
    [Abstract] [Full Text] [Related]

  • 14. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
    Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD, Grant D, Levy G, Renner EL.
    Liver Transpl; 2008 Dec 27; 14(12):1778-86. PubMed ID: 19025914
    [Abstract] [Full Text] [Related]

  • 15. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Bijleveld CM, van den Berg AP, Lems SP, Gouw AS, Slooff MJ.
    Liver Transpl; 2005 Dec 27; 11(12):1541-9. PubMed ID: 16315307
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid-free immunosuppression in pediatric liver transplantation: safety and efficacy after a short-term follow-up.
    Cintorino D, Riva S, Spada M, Minervini M, Sonzogni A, Foglieni CS, Gruttadauria S, Verzaro R, Henderson K, Aricò M, Gridelli B.
    Transplant Proc; 2006 May 27; 38(4):1099-100. PubMed ID: 16757276
    [Abstract] [Full Text] [Related]

  • 17. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW, Firpi RJ, Nelson DR, Schoonhoven R, Shrestha R, Fried MW.
    Liver Transpl; 2005 Oct 27; 11(10):1235-41. PubMed ID: 16184580
    [Abstract] [Full Text] [Related]

  • 18. The clinical significance of early histological rejection with or without biochemical abnormality in adult living donor liver transplantation for hepatitis B virus related end stage liver disease.
    Cho JY, Suh KS, Lee HW, Cho EH, Yang SH, Cho YB, Yi NJ, Kim MA, Jang JJ, Lee KU.
    Transpl Int; 2007 Jan 27; 20(1):37-44. PubMed ID: 17181651
    [Abstract] [Full Text] [Related]

  • 19. Early immunological monitoring after pediatric liver transplantation: cytokine immune deviation and graft acceptance in 40 recipients.
    Gras J, Wieërs G, Vaerman JL, Truong DQ, Sokal E, Otte JB, Délépaut B, Cornet A, de Ville de Goyet J, Latinne D, Reding R.
    Liver Transpl; 2007 Mar 27; 13(3):426-33. PubMed ID: 17318867
    [Abstract] [Full Text] [Related]

  • 20. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.
    Donckier V, Troisi R, Le Moine A, Toungouz M, Ricciardi S, Colle I, Van Vlierberghe H, Craciun L, Libin M, Praet M, Noens L, Stordeur P, Andrien M, Lambermont M, Gelin M, Bourgeois N, Adler M, de Hemptinne B, Goldman M.
    Liver Transpl; 2006 Oct 27; 12(10):1523-8. PubMed ID: 17004249
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.